Pennsylvania 2025_0 Regular Session Status: In Committee Bipartisan · 8 D · 5 R cosponsors

SB 461 — An Act providing for patient access to diagnostics and treatments for Lyme disease and related tick-borne illnesses; and requiring health care policies to provide certain coverage.

Last action — Laid on the table (Pursuant to Senate Rule 9), Sept. 9, 2025

  1. ✓
    Introduced
  2. 2
    In Committee
  3. 3
    Passed Senate
  4. 4
    Passed House
  5. 5
    To Executive
  6. 6
    Enacted

This bill is in committee in the Senate. Introduced March 17, 2025. It must pass committee before a floor vote.

Next likely step: a committee vote, then a floor vote in the Senate.

Odds of enactment

Low chance

Based on the sponsor, cosponsors, and committee posture, this bill has a low chance of becoming law.

Upgrade to see the exact probability and what's driving it.

A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.

Prognosis

Advancing 42% · moderate confidence
  • In Committee

    Current position in the legislative process.

  • 13 sponsors

    1 primary, 12 co-sponsors signed on.

  • Bipartisan support

    Sponsored across 2 parties (8 D · 5 R) — cross-party backing.

Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.

Summary

Improving Lyme Disease Testing and Coverage for Testing in PA

Bill Text

Action History

  1. Laid on the table (Pursuant to Senate Rule 9), Sept. 9, 2025

  2. First consideration, June 11, 2025

  3. Reported as committed, June 11, 2025

  4. Referred to HEALTH AND HUMAN SERVICES, March 17, 2025

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 12 co-sponsors · 240 not signed on

Sponsors (1)

Co-sponsors (12)

Not signed on (240)

240 members have not signed on to this bill.

Show all 240 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does SB 461 do?
Improving Lyme Disease Testing and Coverage for Testing in PA
Who sponsors SB 461?
SB 461 is sponsored by Wayne D. Fontana (Democratic), Jay Costa (Democratic), Lindsey M. Williams (Democratic), Judy Ward (Republican), Michele Brooks (Republican), Maria Collett (Democratic), Steven J. Santarsiero (Democratic), Wayne Langerholc (Republican), Lynda Schlegel Culver (Republican), Carolyn T. Comitta (Democratic), John I. Kane (Democratic), Marty Flynn (Democratic), and Tracy Pennycuick (Republican).
What is the current status of SB 461?
This bill is in committee in the Senate. Introduced March 17, 2025. It must pass committee before a floor vote.
Where can I track SB 461?
Track SB 461 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on SB 461

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Stay ahead of SB 461

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →